An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia

被引:94
作者
Opladen, Thomas [1 ]
Hoffmann, Georg F. [1 ]
Blau, Nenad [1 ,2 ]
机构
[1] Univ Childrens Hosp Heidelberg, Div Inborn Metab Dis, D-69120 Heidelberg, Germany
[2] Univ Childrens Hosp Zurich, Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
DIHYDROPTERIDINE REDUCTASE DEFICIENCY; GTP CYCLOHYDROLASE-I; 6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY; 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE; FOLINIC ACID THERAPY; SEPIAPTERIN REDUCTASE; FOLLOW-UP; BIOPTERIN; NEUROTRANSMITTERS; PHENYLKETONURIA;
D O I
10.1007/s10545-012-9506-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study summarizes clinical and biochemical findings, current treatment strategies and follow-up in patients with tetrahydrobiopterin (BH4) deficiencies. We analyzed the clinical, biochemical and treatment data of 626 patients with BH4 deficiencies [355 with 6-pyruvoyl-tetrahydropterin synthase (PTPS), 217 with dihydropteridine reductase (DHPR), 31 with autosomal recessive GTP cyclohydrolase I (GTPCH), and 23 with pterin-4a-carbinolamine dehydratase (PCD) deficiencies] from the BIODEF Database. Patients with autosomal dominant GTPCH and SR deficiencies will not be discussed in detail. Up to 57 % of neonates with BH4 deficiencies are already clinically symptomatic. During infancy and childhood, the predominant symptoms are muscular hypotonia, mental retardation and age-dependent movement disorders, including dystonia. The laboratory diagnosis of BH4 deficiency is based on a positive newborn screening (NBS) for phenylketonuria (PKU), characteristic profiles of urinary or dried blood spot pterins (biopterin, neopterin, and primapterin), and the measurement of DHPR activity in blood. Some patients with autosomal recessive GTPCH deficiency and all with sepiapterin reductase deficiency may be diagnosed late due to normal blood phenylalanine in NBS. L-dopa, 5-hydroxytryptophan, and BH4 are supplemented in PTPS and GTPCH-deficient patients, whereas L-dopa, 5-hydroxytryptophan, folinic acid and diet are used in DHPR-deficient patients. Medication doses vary widely among patients, and our understanding of the effects of dopamine agonists and monoamine catabolism inhibitors are limited. BH4 deficiencies are a group of treatable pediatric neurotransmitter disorders that are characterized by motor dysfunction, mental retardation, impaired muscle tone, movement disorders and epileptic seizures. Although the outcomes of BH4 deficiencies are highly variable, early diagnosis and treatment result in improved outcomes.
引用
收藏
页码:963 / 973
页数:11
相关论文
共 31 条
[1]   BIOPTERIN-DEPENDENT HYPERPHENYLALANINEMIA DUE TO DEFICIENCY OF 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE [J].
ALAQEEL, A ;
OZAND, PT ;
GASCON, G ;
NESTER, M ;
ALNASSER, M ;
BRISMAR, J ;
BLAU, N ;
HUGHES, H ;
SUBRAMANYAN, SB ;
REYNOLDS, CT .
NEUROLOGY, 1991, 41 (05) :730-737
[2]   International database of tetrahydrobiopterin deficiencies [J].
Blau, N ;
Barnes, I ;
Dhondt, JL .
JOURNAL OF INHERITED METABOLIC DISEASE, 1996, 19 (01) :8-14
[3]  
Blau N., 2006, PHYS GUIDE TREATMENT, P25, DOI DOI 10.1007/3-540-28962-3_3
[4]  
Blau N., 2003, Physician's Guide to the Laboratory Diagnosis of Metabolic Diseases, P89
[5]  
Blau N., 2008, Laboratory guide to the methods in biochemical genetics
[6]  
Blau N., 2001, The Molecular and Metabolic Basis of Inherted Disease, P1725
[7]   Phenylketonuria [J].
Blau, Nenad ;
van Spronsen, Francjan J. ;
Levy, Harvey L. .
LANCET, 2010, 376 (9750) :1417-1427
[8]  
Bonafé L, 2001, CLIN CHEM, V47, P477
[9]   Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia [J].
Bonafé, L ;
Thöny, B ;
Penzien, JM ;
Czarnecki, B ;
Blau, N .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (02) :269-277
[10]   Serum prolactin as a tool for the follow-up of treated DHPR-deficient patients [J].
Concolino, D. ;
Muzzi, G. ;
Rapsomaniki, M. ;
Moricca, M. T. ;
Pascale, M. G. ;
Strisciuglio, P. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 :S193-S197